Home Healthcare

Healthcare

3 Healthcare Stocks - MXC, IMM, AGH

3 Healthcare Stocks – MXC, IMM, AGH

The below-mentioned health care stocks have come up with significant updates today. Let’s take a quick look at these stocks. MGC Pharmaceuticals Ltd (ASX:...

Noxopharm: Developing Veyonda® As A Universal Treatment Of Metastatic Cancer Disease

Clinical-stage drug development company, Noxopharm Limited (ASX: NOX) has released its updated corporate presentation for June 2019. The company, with offices in Sydney, New...
Two Cannabis Stocks - THC and MXC - Spike On Recent Updates

Two Cannabis Stocks – THC and MXC – Spike On Recent Updates

Medical cannabis is becoming popular in the pharmaceutical industry, with more and more countries legalising cannabis for its use as a medicinal product. Growing...

Two Stocks From Healthcare Sector – IMM and TLX

The Australian Healthcare System is amongst the most inclusive in the world, and it offers a wide range of services right from catering to...
3 Healthcare Big Shot Stocks - CSL, COH, RMD

3 Healthcare Big Shot Stocks – CSL, COH, RMD

The three stocks CSL, COH and RMD with higher PE multiple have yielded positive YTD returns. The large cap stocks have performed well in...
Two Healthcare Companies Provide Market Updates: MXC And OCC

Two Healthcare Companies Provide Market Updates: MXC And OCC

MGC Pharmaceuticals Limited (ASX: MXC) is a European company, offering its products and services to the medical cannabis industry. The key business strategy adopted...

CardieX Limited Reports Successful Update On Wearable Tech

CardieX Limited (ASX: CDX) is an Australia registered company involved in the marketing and development of the SphygmoCor® device, which is used for the...
NOX

Noxopharm completes enrolment for the dose expansion arm in DARRT-1 study

Noxopharm Limited (ASX: NOX) recently announced the enrolment of 12th patient  into the dose-expansion arm of DARRT-1 study, which is the company’s first clinical...

Why The Market Opportunity For This ASX Biotech Has Expanded Significantly This Month

Cancer treatment developer Invion Limited (ASX: IVX) could be at an important crossroad as the market opportunity for the company may have more than...
MGC Pharmaceuticals’ Shares Surged Over 5% Post Material Revenue Confirmation

MGC Pharmaceuticals’ Shares Surged Over 5% Post Material Revenue Confirmation

Today, on 4th June 2019, a European based ‘Seed to Pharmacy’ bio-pharma company, MGC Pharmaceuticals Ltd (ASX: MXC) announced its operations and confirmation of...

Recent Posts